Home Newsfeeds Barclays Maintains Underweight on Teradata, Raises Price Target to $35

Barclays Maintains Underweight on Teradata, Raises Price Target to $35

Barclays analyst Raimo Lenschow maintains Teradata (NYSE:TDC) with a Underweight and raises the price target from $33 to $35.

byBenzinga Newsdesk

February 14, 2023

1 minute read

Barclays analyst Raimo Lenschow maintains Teradata (NYSE:TDC) with a Underweight and raises the price target from $33 to $35.

Analyst Ratings

Beyond The Numbers: 7 Analysts Discuss Humana Stock

By Benzinga Insights

January 17, 1:00 PM

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Humana (NYSE:HUM)…

HUM

Raymond James Maintains Outperform on Netgear, Lowers Price Target to $23

By Benzinga Newsdesk

Today, 7:20 AM

Raymond James analyst Adam Tindle maintains Netgear (NASDAQ:NTGR) with a Outperform and lowers the price target from $25 to $23.

NTGR

Boeing’s Commercial Plane Deliveries Decline In April In The Wake Of Manufacturing Adjustments

By Shivani Kumaresan

May 14, 1:04 PM

Amid production enhancements for its 737 MAX, Boeing saw a slight dip in commercial airplane deliveries in April, handing over 24 aircraft compared to 26 the previous year.

FDA AdComm Narrowly Supports Approval Of Sarepta’s Gene Therapy For Rare Neuromuscular Disorder

By Vandana Singh

May 15, 6:53 AM

On Friday, FDA's Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) voted 8 to 6 in support of accelerated approval of Sarepta Therapeutics Inc's (NASDAQ: SRPT) SRP-9001 (delandistrogene moxeparvovec) for ambulatory patients with

SRPT

Barclays Maintains Underweight on Teradata, Raises Price Target to $35

Related Posts

Beyond The Numbers: 7 Analysts Discuss Humana Stock

Raymond James Maintains Outperform on Netgear, Lowers Price Target to $23

Boeing’s Commercial Plane Deliveries Decline In April In The Wake Of Manufacturing Adjustments

FDA AdComm Narrowly Supports Approval Of Sarepta’s Gene Therapy For Rare Neuromuscular Disorder